ACTRN12617001028392已完成1 期
A Phase 1, Single-Center, Five-Period, Single and Multiple Dose, Double-Blind, Placebo-Controlled First-in-Man Study to Assess the Safety and Pharmacokinetics of ZYN001 Administered as a Transdermal Patch to Healthy Adults
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Phase I , single-center, open-label, two-period study to investigate the pharmacokinetics of the DMF-containing formulation FP187-GC in healthy volunteers after oral administration in fasted and fed stateMultiple sclerosispsoriasis10040790NL-OMON43151Forward Pharma GmbH30
已完成
不适用
Phase I, single-center, open-label, two-period study to investigate the pharmacokinetics of the DMF-containing formulation FP187-V2B in healthy volunteers after oral administration in fasted and fed statepsoriasis10040790Multiple sclerosisNL-OMON46121Forward Pharma GmbH30
已完成
1 期
A study of ALMB-0166 administered intravenously to assess tolerability and metabolism of the study drug in healthy participants.Spinal cord injuryInjuries and Accidents - Other injuries and accidentsACTRN12619001689167Avance Clinical Pty Ltd46
已完成
1 期
A phase I trial to study the effect of food on orally dosed IMG-7289 (Bomedemstat) in healthy adult volunteersAcute myeloid leukaemia (AML)Myelodysplastic syndrome (MDS)Cancer - Leukaemia - Acute leukaemiaBlood - Haematological diseasesCancer - Other cancer typesACTRN12621001349831Avance Clinical17
已完成
1 期
A Phase 1, Single-Center, Dose-Ranging, Multi-Treatment Study to Determine the Safety and Pharmacokinetics of Single Oral Dose Combinations of PF329 and Nafamostat Mesilate in Healthy SubjectsACTRN12612000880842Signature Therapeutics, Inc.14